HCMV UL97 phosphotransferase gene mutations may be associated with antiviral resistance in immunocompromised patients in Belém, PA, Northern Brazil

Silva, Dorotéa de Fátima Lobato da; Cardoso, Jedson Ferreira; Silva, Sandro Patroca da; Arruda, Leda Mani França; Medeiros, Renato Lopes Fernandes de; Moraes, Marluce Matos; Sousa, Rita Catarina Medeiros.
Rev. Soc. Bras. Med. Trop ; 51(2): 141-145, Mar.-Apr. 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-897064

Documentos relacionados

  1. Development and validation of a next-generation sequencing assay with open-access analysis software for detecting resistance-associated mutations in CMV.
  2. Drug-resistant cytomegalovirus: clinical implications of specific mutations.
  3. Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection.
  4. Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients.
  5. Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance.
  6. The biology of cytomegalovirus drug resistance.
  7. HCMV UL97 phosphotransferase gene mutations may be associated with antiviral resistance in immunocompromised patients in Belém, PA, Northern Brazil.
  8. Human cytomegalovirus genomics and transcriptomics through the lens of next-generation sequencing: revision and future challenges.
  9. Cytomegalovirus UL97 ganciclovir resistance mutations in kidney transplant recipients.
  10. Patient-Derived Cytomegaloviruses with Different Ganciclovir Sensitivities from UL97 Mutation Retain Their Replication Efficiency and Some Kinase Activity <i>In Vitro</i>.